U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H46NO4P
Molecular Weight 407.568
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MILTEFOSINE

SMILES

CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C

InChI

InChIKey=PQLXHQMOHUQAKB-UHFFFAOYSA-N
InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3

HIDE SMILES / InChI
Molecular Formula C21H46NO4P
Molecular Weight 407.568
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:25:16 UTC 2023
Edited
by admin
on Sat Dec 16 17:25:16 UTC 2023
Record UNII
53EY29W7EC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MILTEFOSINE
DASH   INN   MART.   MI   WHO-DD  
INN  
Official Name English
IMPAVIDO
Brand Name English
MILTEFOSINE [MI]
Common Name English
miltefosine [INN]
Common Name English
D-18506
Code English
HDPC
Common Name English
Miltefosine [WHO-DD]
Common Name English
MILTEFOSINE [ORANGE BOOK]
Common Name English
MILTEFOSINE [MART.]
Common Name English
NSC-758968
Code English
NSC-605583
Code English
Classification Tree Code System Code
NCI_THESAURUS C2188
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 6.5.2
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
WHO-VATC QL01XX09
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
FDA ORPHAN DRUG 229406
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
FDA ORPHAN DRUG 540216
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
FDA ORPHAN DRUG 590217
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
NDF-RT N0000190851
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
FDA ORPHAN DRUG 275409
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
EU-Orphan Drug EU/3/05/282
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
WHO-ATC L01XX09
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
FDA ORPHAN DRUG 565016
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
FDA ORPHAN DRUG 565216
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
FDA ORPHAN DRUG 565116
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
FDA ORPHAN DRUG 843921
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
Code System Code Type Description
NSC
605583
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
DAILYMED
53EY29W7EC
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
PUBCHEM
3599
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
NCI_THESAURUS
C1170
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
CAS
58066-85-6
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
INN
6362
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
FDA UNII
53EY29W7EC
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
MERCK INDEX
m7549
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY Merck Index
CHEBI
75283
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
DRUG CENTRAL
1810
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
WIKIPEDIA
Miltefosine
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
MESH
C039128
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
EVMPD
SUB08969MIG
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
SMS_ID
100000091387
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
DRUG BANK
DB09031
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
RXCUI
1494066
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY RxNorm
EPA CompTox
DTXSID7045942
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
ChEMBL
CHEMBL125
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
NSC
758968
Created by admin on Sat Dec 16 17:25:16 UTC 2023 , Edited by admin on Sat Dec 16 17:25:16 UTC 2023
PRIMARY
Related Record Type Details
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
Structure of MILTEFOSINE
EXCRETED UNCHANGED
The urinary excretion of the unchanged drug on Day 23 after repeated oral administration of miltefosine to adult patients was below 0.2% of the daily dose
URINE
Related Record Type Details
Structure of CHOLINE
METABOLITE INACTIVE -> PARENT
PLASMA
Related Record Type Details
Structure of MILTEFOSINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966